Mounting evidence for Angtotensin Receptor Blockcrs in clinical medicine

JA Ker; J Ker

Mounting evidence for Angtotensin Receptor Blockcrs in clinical medicine

JA Ker University of Pretoria
J Ker University of Pretoria

Abstract

The Renin-Angiotensin-Aldosteron System (RAAS) participates in the pathophysiology of systemic hyper-tension, heart failure and diabetic nephropathy. Moreover, excessive activation of the RAAS may increase the risk of cardiovascular morbidity and mortality. Therefore, blocking this system (RAAS) maybe expected to reduce cardiovascular morbidity and mortality.

Author Biographies

JA Ker, University of Pretoria

MMed(Int) MD, Department of Internal Medicine, School of Medicine

J Ker, University of Pretoria

MMed(Int) Department of Physiology, School of Medicine

Issue

Vol 45 No 7 (2003)

Section

CPD

By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the South African Academy of Family Physicians. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.